About this trial
The goal of this clinical trial is to compare protein supplements in patients with kidney failure on dialysis. The main questions it aims to answer are:
* To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible. * To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements. * To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
Eligibility criteria
Qualifiers
Participant is willing and able to give informed consent for participation in the trial
Male or female aged ≥18 years with CKD
On chronic in-center hemodialysis for > 3 months
Serum albumin <35 g/L
Disqualifiers
Allergy to eggs
History of renal transplant
Serum albumin ≥ 35 g/L
Bowel diseases
Trial design
Treatments tested in this trial
- Egg white protein pudding
- : Ensure Plus
Treatment groups
Sponsors and collaborators
Seven Oaks Hospital Chronic Disease Innovation Centre
Lead sponsor
University of Manitoba
Collaborator
Manitoba Egg Farmers
Collaborator